AUTO3

CD19/CD22 CAR T cells · Autolus Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUTO3, covering 2021-02-01 to 2021-02-01. Get the full timeline:

Most recent: Clinical Trial Update: CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) [Phase 1, Phase 2]